Enrique Sanz-Garcia

14PUBLICATIONS
154CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 30, 2026
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

|Apr 04, 2026
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerillo

|Feb 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection.

Yong Zeng, Dor D Abelman, Althaf Singhawansa

|Dec 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia

Pageof 3

Frequent Collaborators

5 joint publications

Lillian L Siu

4 joint publications

Scott V Bratman

3 joint publications

Trevor J Pugh

3 joint publications

Philippe L Bedard